Brief: Upnorth Investment Limited Reports 9.2 Pct Passive Stake In Tcr2 Therapeutics Inc As Of Feb 13, 2019 - SEC Filing
22/02/2019 11:26
Feb 22 (Reuters) - Tcr2 Therapeutics Inc TCRR.O :
* UPNORTH INVESTMENT LIMITED REPORTS 9.2 PERCENT PASSIVE
STAKE IN
TCR2 THERAPEUTICS INC AS OF FEB 13, 2019 - SEC FILING
Source: (https://bit.ly/2U3lDjF)
Further company coverage: TCRR.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview